To hear about similar clinical trials, please enter your email below
Trial Title:
The Use of Virtual Reality in Rehabilitation in Patients After Vestibular Schwannoma Surgery.
NCT ID:
NCT05578560
Condition:
Acute Peripheral Vestibulopathy Following Surgical Procedure
Conditions: Official terms:
Neurilemmoma
Neuroma, Acoustic
Vestibular Neuronitis
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Prehabituation
Description:
chemical labyrinthectomy with intratympanically installed gentamicin
Arm group label:
Prehabituation group
Intervention type:
Procedure
Intervention name:
3D optokinetic stimulation in virtual reality space
Description:
3D optokinetic stimulation via virtual reality goggles with the software designed by
Pro-Zeta comp.
Arm group label:
Virtual reality group
Intervention type:
Procedure
Intervention name:
Vestibular training
Description:
vestibular training program adopted for patients with acute vestibular loss under the
supervision of a physical therapist. The program includes gaze stability exercises,
smooth pursuit, and saccadic eye movements, and postural exercises to improve balance
control and gait stability. Each session lasts around 30 minutes and happened daily for
the 7 postoperative days.
Arm group label:
Prehabituation group
Arm group label:
Vestibular training group
Arm group label:
Virtual reality group
Summary:
Resection of the vestibular schwannoma leads to acute peripheral or combined vestibular
loss caused by a surgical lesion to the branches of the vestibular nerve and, less
frequently also the lesion of the cerebellum. The lesion presents in patients with
postural instability, vertigo, oscillopsia, and vegetative symptoms that may accompany
it. The organism reacts to this state with the process of central compensation with the
significant role of the cerebellum. The goal of the rehabilitation is to support this
process and thus to make recovery faster and more efficient since not all patients are
capable of complete restoration of the vestibular function. Up to date, rehabilitation
includes, apart from the specific vestibular exercise, also the possibility of modern
techniques using virtual reality space and prehabituation. Thanks to prehabituation,
i.e., chemical labyrinthectomy with intratympanically installed gentamicin, the timing of
the origin of the acute vestibular loss and the surgical procedure is separated.
Therefore, there is a chance of achieving vestibular compensation before vestibular
schwannoma removal. In the last decade, due to the advances in technology in the field of
computer games and the applications for smartphones, the tools for virtual reality have
become less expensive and more available in common praxis. Virtual reality is a technique
for generating an environment that can strengthen three-dimensional optokinetic
stimulation, subsequently the process of central compensation. Overall, it may shorten
the time of recovery after the surgery and improve patients' quality of life.
Detailed description:
This study was approved by institutional ethics committee of the University Hospital
Motol and all patients provide inform consent prior to study commencement.
In this prospective randomized single-center study, we will enroll patients who undergo
vestibular schwannoma resection in our department. All patients must be found to be
indicated for the surgery. The size of the tumor will be classified according to the Koos
classification. The patients with hearing loss will undergo prehabituation (group A). The
rest of the patients will be randomly divided into either a virtual reality group (group
B), or the control group (group C). Two days before the surgery (time 1) all of the
patients will undergo a clinical oto-neurological examination as well as examination by
objective methods - video-nystagmography (VNG), air calorics, video Head Impulse Test
(vHIT), and cervical Vestibular Evoked Myogenic Potentials (cVEMP). They will also fill
out a set of questionnaires - the Penn Acoustic Neuroma Quality-Of-Life scale (PANQOL),
Dizziness Handicap Inventory (DHI), Generalized Anxiety Disorder 7 - item scale (GAD-7),
and Self-rating Depression Scale (SDS). All of them were translated into the Czech
language. In addition to it, we used the in-house questionnaire focused on vertigo
symptoms.
On the second day after the surgery, all groups of patients begin to practice the
vestibular training program adopted for patients with acute vestibular loss under the
supervision of a physical therapist. The program includes gaze stability exercises,
smooth pursuit, and saccadic eye movements, and postural exercises to improve balance
control and gait stability. Each session will last around 30 minutes and will happen
daily for the whole time of the hospitalization, thus seven days. Additionally, during
that time, group B will obtain seven sessions of 30-minute-long optokinetic stimulation
via virtual reality goggles. Subjective and objective assessments will be repeated at the
hospital discharge which is on the 7-10th postoperative day (time 2) and 3 months after
surgery (time 3).
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Vestibular Schwannoma appropriate to surgical resection
Exclusion Criteria:
- Eye disorder
- Oculomotor disorder in patient history
- Nerve palsy other than n. VIII, n. VII.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine Charles University and Motol University Hospital, Postgraduate Medical School
Address:
City:
Prague
Zip:
15006
Country:
Czechia
Status:
Recruiting
Contact:
Last name:
Bonaventurova
Phone:
+420722983690
Email:
Marketa.Bonaventurova@fnmotol.cz
Start date:
January 1, 2020
Completion date:
June 2026
Lead sponsor:
Agency:
Charles University, Czech Republic
Agency class:
Other
Source:
Charles University, Czech Republic
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05578560